Traws Pharma, Inc. — Director's Dealing 2018

Nov 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2018-11-05

Reporting Person: Woodman Richard Charles (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-05	Stock Option (right to buy)	$5.82	A	20000	Acquired	2028-11-05	Common Stock (20000)	Direct

Footnotes

F1: These options vest over 4 years. 25% on the first anniversary of the grant date and the remainder in 36 equal monthly installments over the last 3 years.